Starlake Bioscience Co Inc Zhaoqing Guangdong Cash Flow-to-Debt Ratio
Starlake Bioscience Co Inc Zhaoqing Guangdong cash flow-to-debt ratio. Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) has a Cash Flow-to-Debt Ratio of 0.14x as of September 2025, meaning its operating cash flow of CN¥1.25 Billion could theoretically repay 0% of its total liabilities (CN¥8.77 Billion) in one year. Check Starlake Bioscience Co Inc Zhaoqing Guan cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Starlake Bioscience Co Inc Zhaoqing Guangdong (1998–2025)
Cash flow-to-debt ratio of Starlake Bioscience Co Inc Zhaoqing Guangdong from 1998 to 2025. Historical debt coverage capacity for Starlake Bioscience Co Inc Zhaoqing Guangdong across 28 annual periods. Check Starlake Bioscience Co Inc Zhaoqing Guan (600866) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Starlake Bioscience Co Inc Zhaoqing Guangdong Cash Flow-to-Debt Ratio by Year (1998–2025)
Starlake Bioscience Co Inc Zhaoqing Guangdong cash flow-to-debt ratio by year from 1998 to 2025. Year-by-year debt coverage analysis for Starlake Bioscience Co Inc Zhaoqing Guangdong. For the full cash flow conversion analysis, see cash efficiency ratio of Starlake Bioscience Co Inc Zhaoqing Guan.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.15x | CN¥1.29 Billion | CN¥8.79 Billion | ▼ -60.0% |
| 2024 | 0.37x | CN¥2.40 Billion | CN¥6.52 Billion | ▲ +22.1% |
| 2023 | 0.30x | CN¥2.03 Billion | CN¥6.73 Billion | ▲ +64.3% |
| 2022 | 0.18x | CN¥1.66 Billion | CN¥9.07 Billion | ▼ -33.6% |
| 2021 | 0.28x | CN¥192.63 Million | CN¥697.74 Million | ▼ -16.8% |
| 2020 | 0.33x | CN¥249.99 Million | CN¥752.97 Million | ▼ -7.2% |
| 2019 | 0.36x | CN¥213.17 Million | CN¥595.95 Million | ▲ +245.0% |
| 2018 | 0.10x | CN¥50.69 Million | CN¥488.94 Million | ▲ +38.4% |
| 2017 | 0.07x | CN¥40.05 Million | CN¥534.57 Million | ▲ +16.1% |
| 2016 | 0.06x | CN¥41.17 Million | CN¥637.90 Million | ▲ +1771.0% |
| 2015 | 0.00x | CN¥2.75 Million | CN¥795.88 Million | ▲ +113.4% |
| 2014 | -0.03x | CN¥-20.22 Million | CN¥787.37 Million | ▼ -3.8% |
| 2013 | -0.02x | CN¥-28.16 Million | CN¥1.14 Billion | ▲ +84.8% |
| 2012 | -0.16x | CN¥-276.02 Million | CN¥1.70 Billion | ▼ -499.7% |
| 2011 | 0.04x | CN¥65.88 Million | CN¥1.62 Billion | ▼ -72.9% |
| 2010 | 0.15x | CN¥104.63 Million | CN¥698.07 Million | ▼ -77.4% |
| 2009 | 0.66x | CN¥316.73 Million | CN¥477.36 Million | ▲ +158.6% |
| 2008 | 0.26x | CN¥148.93 Million | CN¥580.44 Million | ▲ +89.4% |
| 2007 | 0.14x | CN¥82.28 Million | CN¥607.29 Million | ▲ +99.3% |
| 2006 | 0.07x | CN¥35.14 Million | CN¥516.89 Million | ▼ -28.9% |
| 2005 | 0.10x | CN¥46.83 Million | CN¥489.57 Million | ▲ +35.3% |
| 2004 | 0.07x | CN¥29.05 Million | CN¥410.86 Million | ▼ -87.4% |
| 2003 | 0.56x | CN¥149.70 Million | CN¥266.82 Million | ▼ -42.1% |
| 2002 | 0.97x | CN¥183.18 Million | CN¥188.89 Million | ▲ +292.2% |
| 2001 | 0.25x | CN¥60.82 Million | CN¥245.97 Million | ▼ -12.2% |
| 2000 | 0.28x | CN¥93.41 Million | CN¥331.53 Million | ▼ -23.5% |
| 1999 | 0.37x | CN¥52.97 Million | CN¥143.87 Million | ▼ -14.3% |
| 1998 | 0.43x | CN¥71.14 Million | CN¥165.54 Million | — |